Found: 89
Select item for more details and to access through your institution.
Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance.
- Published in:
- Clinical & Translational Gastroenterology, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41424-018-0021-8
- By:
- Publication type:
- Article
"Salvage techniques" are the key to overcome difficult biliary cannulation in endoscopic retrograde cholangiopancreatography.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17809-5
- By:
- Publication type:
- Article
Phase II study comparing nasal pressure monitoring with capnography during invasive endoscopic procedures: a single-center, single-arm trial.
- Published in:
- Scientific Reports, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28213-y
- By:
- Publication type:
- Article
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00889-0
- By:
- Publication type:
- Article
Diverse transitions in diabetes status during the clinical course of patients with resectable pancreatic cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1403, doi. 10.1093/jjco/hyaa136
- By:
- Publication type:
- Article
Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 19, p. 12015, doi. 10.3390/ijms231912015
- By:
- Publication type:
- Article
Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 906, doi. 10.3390/ijms18050906
- By:
- Publication type:
- Article
The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25218-x
- By:
- Publication type:
- Article
The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25350-8
- By:
- Publication type:
- Article
Practicality of STAT3 Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2023, p. 1, doi. 10.1155/2023/6682459
- By:
- Publication type:
- Article
Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells.
- Published in:
- Stem Cells International, 2019, p. 1, doi. 10.1155/2019/9789240
- By:
- Publication type:
- Article
Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 4, p. 394, doi. 10.1007/s10637-024-01441-3
- By:
- Publication type:
- Article
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 172, doi. 10.1007/s10637-019-00801-8
- By:
- Publication type:
- Article
Characteristics of patients with sorafenib-treated advanced hepatocellular carcinoma eligible for second-line treatment.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 332, doi. 10.1007/s10637-017-0507-3
- By:
- Publication type:
- Article
Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 2, p. 255, doi. 10.1007/s10637-016-0323-1
- By:
- Publication type:
- Article
Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1257, doi. 10.1007/s10637-015-0292-9
- By:
- Publication type:
- Article
Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 729, doi. 10.1007/s10637-015-0237-3
- By:
- Publication type:
- Article
Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis.
- Published in:
- International Journal of Clinical Oncology, 2022, v. 27, n. 9, p. 1459, doi. 10.1007/s10147-022-02195-9
- By:
- Publication type:
- Article
Is intra-patient sorafenib dose re-escalation safe and tolerable in patients with advanced hepatocellular carcinoma?
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 6, p. 1029, doi. 10.1007/s10147-014-0668-4
- By:
- Publication type:
- Article
Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2022, v. 52, n. 12, p. 1060, doi. 10.1111/hepr.13827
- By:
- Publication type:
- Article
Real‐world outcomes of molecular targeted agents for patients with hepatocellular carcinoma over 80 years old.
- Published in:
- Hepatology Research, 2022, v. 52, n. 10, p. 859, doi. 10.1111/hepr.13818
- By:
- Publication type:
- Article
Tolvaptan treatment for patients with decompensated cirrhosis and advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 10, p. E161, doi. 10.1111/hepr.12465
- By:
- Publication type:
- Article
A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0125244
- By:
- Publication type:
- Article
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084807
- By:
- Publication type:
- Article
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0070010
- By:
- Publication type:
- Article
Evolving Treatment of Advanced Hepatocellular Carcinoma in the Asia–Pacific Region: A Review and Multidisciplinary Expert Opinion.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2626, doi. 10.3390/cancers13112626
- By:
- Publication type:
- Article
Skeletal Muscle Volume Is an Independent Predictor of Survival after Sorafenib Treatment Failure for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2247, doi. 10.3390/cancers13092247
- By:
- Publication type:
- Article
Changes in therapeutic options for hepatocellular carcinoma in Asia.
- Published in:
- Liver International, 2022, v. 42, n. 9, p. 2055, doi. 10.1111/liv.15101
- By:
- Publication type:
- Article
Changes in therapeutic options for hepatocellular carcinoma in Asia.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 2055, doi. 10.1111/liv.15101
- By:
- Publication type:
- Article
A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
A phase I/II study of S-1 with sorafenib in patients with advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 723, doi. 10.1007/s10637-014-0077-6
- By:
- Publication type:
- Article
A phase I/II trial of capecitabine combined with peginterferon α-2a in Patients with sorafenib-refractory advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 762, doi. 10.1007/s10637-014-0097-2
- By:
- Publication type:
- Article
Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 2, p. 193, doi. 10.1159/000531820
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 4, p. 309, doi. 10.1159/000529636
- By:
- Publication type:
- Article
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 354, doi. 10.1159/000522547
- By:
- Publication type:
- Article
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 4, p. 329, doi. 10.1159/000522389
- By:
- Publication type:
- Article
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 48, doi. 10.1159/000519868
- By:
- Publication type:
- Article
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
- By:
- Publication type:
- Article
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 275, doi. 10.1159/000515553
- By:
- Publication type:
- Article
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 181, doi. 10.1159/000514174
- By:
- Publication type:
- Article
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 596, doi. 10.1159/000508809
- By:
- Publication type:
- Article
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 583, doi. 10.1159/000508724
- By:
- Publication type:
- Article
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 382, doi. 10.1159/000507022
- By:
- Publication type:
- Article
Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 9, p. 10625, doi. 10.1002/cam4.5810
- By:
- Publication type:
- Article
Switching to systemic therapy after locoregional treatment failure: Definition and best timing.
- Published in:
- Clinical & Molecular Hepatology, 2020, v. 26, n. 2, p. 155, doi. 10.3350/cmh.2019.0021n
- By:
- Publication type:
- Article
Cabozantinib for Advanced Hepatocellular Carcinoma in the Latest Real-World Practice: A Multicenter Retrospective Analysis.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 4, p. 513, doi. 10.1007/s40801-023-00379-x
- By:
- Publication type:
- Article
Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2022, v. 27, n. 3, p. 1, doi. 10.1016/j.aohep.2022.100696
- By:
- Publication type:
- Article
Outcomes for Underwater Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection of 21–30-mm Colorectal Polyps: A Feasible Study.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 10, p. 3963, doi. 10.1007/s10620-023-08093-y
- By:
- Publication type:
- Article